Does rosuvastatin offer therapeutic potential in autoimmune thyroiditis in nonobese diabetic mice?
Mori
Kouki
K
Nakagawa
Yoshinori
Y
Hoshikawa
Saeko
S
Ozaki
Hiroshi
H
Ito
Sadayoshi
S
Yoshida
Katsumi
K
D000818:Animals; D000906:Antibodies / Q000097:blood; D005464:Fluorobenzenes / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D051379:Mice; D016688:Mice, Inbred NOD; D011743:Pyrimidines / Q000494:pharmacology* / Q000627:therapeutic use; D000068718:Rosuvastatin Calcium; D012974:Sodium Iodide / Q000494:pharmacology; D013154:Spleen / Q000166:cytology / Q000187:drug effects; D013449:Sulfonamides / Q000494:pharmacology* / Q000627:therapeutic use; D013954:Thyroglobulin / Q000494:pharmacology; D013967:Thyroiditis, Autoimmune / Q000139:chemically induced / Q000188:drug therapy
D000906:Antibodies; D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium; D013954:Thyroglobulin; D012974:Sodium Iodide